- Home
- SGC vs HRTX Comparison
SGC vs HRTX Comparison
Compare SGC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- HRTX
- Stock Information
- Founded
- SGC 1920
- HRTX 1983
- Country
- SGC United States
- HRTX United States
- Employees
- SGC N/A
- HRTX N/A
- Industry
- SGC Apparel
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- SGC Consumer Discretionary
- HRTX Health Care
- Exchange
- SGC Nasdaq
- HRTX Nasdaq
- Market Cap
- SGC 281.4M
- HRTX 350.4M
- IPO Year
- SGC N/A
- HRTX 1987
- Fundamental
- Price
- SGC $10.47
- HRTX $2.17
- Analyst Decision
- SGC Strong Buy
- HRTX Strong Buy
- Analyst Count
- SGC 2
- HRTX 2
- Target Price
- SGC $19.00
- HRTX $5.50
- AVG Volume (30 Days)
- SGC 44.8K
- HRTX 1.8M
- Earning Date
- SGC 05-08-2025
- HRTX 05-06-2025
- Dividend Yield
- SGC 5.35%
- HRTX N/A
- EPS Growth
- SGC 35.19
- HRTX N/A
- EPS
- SGC 0.73
- HRTX N/A
- Revenue
- SGC $565,676,000.00
- HRTX $148,518,000.00
- Revenue This Year
- SGC $4.67
- HRTX $11.18
- Revenue Next Year
- SGC $5.01
- HRTX $13.15
- P/E Ratio
- SGC $14.34
- HRTX N/A
- Revenue Growth
- SGC 4.12
- HRTX 12.43
- 52 Week Low
- SGC $9.11
- HRTX $1.04
- 52 Week High
- SGC $21.80
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- SGC 47.42
- HRTX 49.30
- Support Level
- SGC $10.10
- HRTX $2.00
- Resistance Level
- SGC $10.74
- HRTX $2.61
- Average True Range (ATR)
- SGC 0.39
- HRTX 0.18
- MACD
- SGC 0.10
- HRTX 0.01
- Stochastic Oscillator
- SGC 71.58
- HRTX 45.00
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.